A widely used is diabetes The drug has just received significant new approval, possibly the lives of millions of Americans have been changed to the risk of kidney failure. US Food and Drug Administration (FDA) has officially approved Ozapic To help reduce the risk of severe renal complications in people with type 2 diabetes and chronic kidney disease.

How can it be a game-shineer Kidney health

Type 2 is one of the major causes of diabetes chronic kidney disease (CKD), which affects more than 1 adults in the United States. So far, treatment options have been limited to prevent kidney failure in these patients. With this new approval, doctors can now prescribe ozmpic to reduce the risk of death from kidney failure, dialysis and heart -related complications in high -risk patients.

“Over the last 20 years, this is an area where researchers worked hard, but have reached very little,” the creator of the Ozapic, “Dr. Novo Nordisk, Senior Vice President of Global Medical Affairs, Dr.. Stephen Gaff said. “Doing something new in this way is really exciting and promises patients.”

Ozapics have already been used to help manage Blood sugar level And reduce the risk of heart disease in people with type 2 diabetes. The latest FDA approval is based on research in which it is shown that people with both types of type 2 diabetes and chronic kidney disease were at risk of complications related to 24 percent less kidney, such as dialysis or kidney transplant was needed . Additionally, the study found that these patients experienced a slow decline in kidney function and less likely to die from heart problems.

Kidney specialist of Bath Israel Decoration Medical Center in Boston, Dr. Melani Honig said, “The more we can delay the decline in the kidney function, it would be better.”

What is the reason for type 2 diabetes?

Type 2 diabetes develops when the body becomes resistant to insulin, a hormone that helps regulate blood sugar levels. It leads to high-to-normal blood sugar levels, causing prolonged damage to organs including kidneys. Many factors contribute to the development of type 2 diabetes, including:

– Obesity and unhealthy diet – excess weight, especially around the stomach, increases insulin resistance. High diets in processed foods, sugar and unhealthy fat can also increase risk.

– Lack of physical activity – A sedentary lifestyle reduces insulin sensitivity, making it difficult for the body to regulate blood sugar levels.

– Genesis and Family History – If a close relative, such as parents or brother -in -law, type 2 diabetes, the risk of developing the condition is high.

– Age – While type 2 diabetes can occur at any age, the risk increases significantly after the age of 45 years.

– High blood pressure and cholesterol- These conditions can contribute to insulin resistance and can increase the risk of complications related to diabetes, including kidney disease.

Challenges with ozapic availability

Although ozmpic is often associated with weight loss, it is mainly approved for blood sugar control. Researchers believe that the drug can also reduce renal inflammation, contribute to its new protective benefits.

Doctors usually prescribe drugs to manage blood sugar, blood pressure and cholesterol to help protect kidney function. However, treatment options remain limited, which leads to an important success of ozmpic.

Despite its benefits, there is increasing concern over the availability of the drug. Due to high demand, the FDA currently lists semaglutide – as active compounds and weight loss drug vegovi – in the form of vago – as a deficiency of.

“Many people, unfortunately, cannot get it,” Dr. Honig said. “But if they can, and it works for them, it is a wonderful thing to have more equipment.”

With this new approval, the demand for ozmpic is expected to increase further. As more people see to use the drug, experts emphasize the importance of ensuring availability so that people who are required for life-threatening conditions like kidney disease can get treatment without delay. .

Now get the latest news with health and braking news and top headlines worldwide.